With much of Moderna’s rise in this decade tied to its COVID-19 vaccine, the company has struggled in recent years to match ...

CAMBRIDGE, MA / ACCESSWIRE / May 2, 2023 /Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced plans to establish an ...

Announces three-year business strategy and commercial growth drivers, targeting up to 10% revenue growth in 2026 Expects to ...

(Reuters) -Moderna said its Chief Commercial Officer Arpa Garay has stepped down from the role and CEO Stephane Bancel will look over sales and marketing, sending the shares of the vaccine maker down ...

Moderna secured a $1.5 billion loan from Ares Management, structured in three tranches, to support financial flexibility and ...

CAMBRIDGE, MA / ACCESSWIRE / December 12, 2023 / Moderna, Inc. (NASDAQ:MRNA) today announced changes to its operating model to bring focus to its short- and long-term business goals. The Company is ...

As Moderna awaits the arrival of the commercial COVID-19 vaccine market in the U.S., the toll of waning demand worldwide has become painfully apparent. For all of 2022, the mRNA specialist logged a $1 ...

Moderna announced Tuesday that it has hired Chantal Friebertshäuser as SVP of commercial for Europe, the Middle East and Canada. Most recently, Friebertshäuser served in global commercial leadership ...

Corinne Le Goff has been appointed president, CEO and director at Celsion, the clinical-stage biotech announced. Michael Tardugno, the company’s former president and CEO, will continue to serve as ...

Moderna’s stock has seen a notable shift in sentiment after its fair value estimate was cut from $40.30 to $37.32. This ...

CAMBRIDGE, MA / ACCESSWIRE / April 27, 2022 / Moderna, Inc., (NASDAQ:MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that Arpa Garay will join ...